Laddar...
The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer.
Expression of estrogen and progesterone hormone receptors indicates a favorable prognosis due to the successful use of hormonal therapies such as tamoxifen and aromatase inhibitors. Unfortunately, 15-20% of patients will experience breast cancer recurrence despite continued use of tamoxifen. Drug re...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Public Library of Science (PLoS)
2012-01-01
|
| Serie: | PLoS ONE |
| Länkar: | http://europepmc.org/articles/PMC3468546?pdf=render |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|